
Healthcare4 min read
Insilico says its AI-designed lung drug lowered biological age markers in a 42-patient trial
Covered by 2 sources
Every AI story we track on Insilico Medicine — 2 stories so far, each summarized in our own words and linked back to the publisher that reported it.

